The effectiveness of tivantinib for MET-high hepatocellular carcinoma: A protocol for meta analysis

The efficacy of tivantinib for MET-high hepatocellular carcinoma remains controversial. We conduct this meta-analysis to explore the efficacy of tivantinib versus placebo for MET-high hepatocellular carcinoma. METHODS: We have searched PubMed, EMbase, Web of science, EBSCO, and Cochrane library data...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yubin, Xu, Hao, Yang, Juan, Zhang, Juyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118349/
https://www.ncbi.nlm.nih.gov/pubmed/37083791
http://dx.doi.org/10.1097/MD.0000000000032591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118349/
https://www.ncbi.nlm.nih.gov/pubmed/37083791
http://dx.doi.org/10.1097/MD.0000000000032591

Ejemplares similares